Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

Act" was unveiled by a group of bipartisan lawmakers Tuesday, aimed at reforming the incentive structure for Pharmacy Benefit ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Dr. Mehmet Oz, the former surgeon and television host, was nominated to head the Centers for Medicare and Medicaid Services.

Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...

President Trump’s Justice Department will defend Biden’s Inflation Reduction Act and its dangerous price controls on ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

The American Society of Health-System Pharmacists warned the extra costs from tariffs, combined with Biden-era penalties levied on drug companies that raise prices more than the rate of inflation ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...